Detalhe da pesquisa
1.
Proscillaridin A inhibits lung cancer cell growth and motility through downregulation of the EGFR-Src-associated pathway.
Am J Cancer Res
; 13(11): 5352-5367, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38058797
2.
Peruvoside is a novel Src inhibitor that suppresses NSCLC cell growth and motility by downregulating multiple Src-EGFR-related pathways.
Am J Cancer Res
; 12(6): 2576-2593, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35812056
3.
Paired-like homeodomain 2B contributes to tumour progression and anti-autophagy in human lung cancer.
Am J Cancer Res
; 11(10): 4900-4918, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34765299
4.
Pharmacophore-based virtual screening for the identification of the novel Src inhibitor SJG-136 against lung cancer cell growth and motility.
Am J Cancer Res
; 10(6): 1668-1690, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32642283
5.
Mechanical stretch induces endothelial nitric oxide synthase gene expression in neonatal rat cardiomyocytes.
Clin Exp Pharmacol Physiol
; 36(5-6): 559-66, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19673940
6.
Oncogenic miR-137 contributes to cisplatin resistance via repressing CASP3 in lung adenocarcinoma.
Am J Cancer Res
; 6(6): 1317-30, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27429846
7.
Increased risk of community-acquired pneumonia in COPD patients with comorbid cardiovascular disease.
Int J Chron Obstruct Pulmon Dis
; 11: 3051-3058, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27980402
8.
Tumour suppressor HLJ1: A potential diagnostic, preventive and therapeutic target in non-small cell lung cancer.
World J Clin Oncol
; 5(5): 865-73, 2014 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-25493224
9.
Prior EGFR tyrosine-kinase inhibitor therapy did not influence the efficacy of subsequent pemetrexed plus platinum in advanced chemonaïve patients with EGFR-mutant lung adenocarcinoma.
Onco Targets Ther
; 7: 799-805, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24920920